The Motley Fool··Jack DelaneySmall-Cap Biotech vs. Pharma Giants: Navigating Risk and Reward in Healthcare
Small-cap biotech like CTMX offers explosive growth potential but carries significant risk; megacap pharma like JNJ provides stability and dividends with moderate returns.
JNJCTMXstock volatilityportfolio diversification